Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy.

作者: Athanasios K. Roumeliotis , Stefanos K. Roumeliotis , Stylianos A. Panagoutsos , Fotis Tsetsos , Marianthi Georgitsi

DOI: 10.1007/S11255-017-1755-Z

关键词:

摘要: Cardiovascular (CV) events are the first cause of death in patients with chronic renal disease (CKD) and type 2 diabetes mellitus (DM2). The combination CKD DM2 elevates risk both cardiovascular (CVD) this high-risk population. Besides traditional factors, such as dyslipidemia, smoking, obesity, carotid atherosclerosis, novel factors under investigation genetic polymorphisms. Lipoxygenases (LOXs) their genes critical importance oxidative stress, inflammation, atherosclerosis. aim study is to clarify a potential ALOX12 role CVD presence progress diabetic different stages nephropathy. We studied 145 documented history for at least 10 years nephropathy (DN), mean age 68 ± 9 years, body mass index 31 ± 5 kg/m2, disease, depending on glomerular filtration rate. sample population consisted two groups: 108 DN all five 37 controls. Anthropometric clinical characteristics, interview previous CV event, assessment intima-media thickness (cIMT) were recorded baseline. All genotyped polymorphisms focus rs14309. Genotypes (AA, AG, GG) evaluated any possible CVD, grouping was performed A genotype, which dominant model. participants followed over period 7 years, end points all-cause mortality, events. defined myocardial infarction (MI), stroke, or peripheral artery disease. GG genotype has been significantly associated cIMT levels above 0.86 mm MI. Regarding an atherosclerotic plaque either artery, no significant association found when genotypes assessed own. After grouping, though, revealed between formation atheromatosis. Kaplan–Meier analysis that gene predicted Similarly, AA AG grouped, showed presented even more higher compared combined. adjustment several multivariate Cox proportional hazard had threefold increase twofold increased genotype. rs14309 expression be MI, cIMT, events, CV, overall mortality. This phenomenon could partially explained by platelet proaggregatory activity products control they exert thrombotic occurrence formation.

参考文章(30)
Anna Tavridou, Anastasia Georgoulidou, Athanasios Roumeliotis, Stefanos Roumeliotis, Efstathia Giannakopoulou, Nikolaos Papanas, Ploumis Passadakis, Vangelis G Manolopoulos, Vassilis Vargemezis, None, Association of Plasma Adiponectin and Oxidized Low-Density Lipoprotein with Carotid Intima-Media Thickness in Diabetic Nephropathy Experimental Diabetes Research. ,vol. 2015, pp. 507265- 507265 ,(2015) , 10.1155/2015/507265
Domenico Praticò, Victoria Zhukareva, Yuemang Yao, Kunihiro Uryu, Colin D. Funk, John A. Lawson, John Q. Trojanowski, Virginia M.-Y. Lee, 12/15-Lipoxygenase Is Increased in Alzheimer's Disease: Possible Involvement in Brain Oxidative Stress American Journal of Pathology. ,vol. 164, pp. 1655- 1662 ,(2004) , 10.1016/S0002-9440(10)63724-8
Avonne E. Connor, Richard N. Baumgartner, Kathy B. Baumgartner, Christina M. Pinkston, Stephanie D. Boone, Esther M. John, Gabriela Torres- Mejía, Lisa M. Hines, Anna R. Giuliano, Roger K. Wolff, Martha L. Slattery, Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study. Molecular Carcinogenesis. ,vol. 54, pp. 1541- 1553 ,(2015) , 10.1002/MC.22228
David Bleich, Songyuan Chen, Brian Zipser, Duxin Sun, Colin D. Funk, Jerry L. Nadler, Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice Journal of Clinical Investigation. ,vol. 103, pp. 1431- 1436 ,(1999) , 10.1172/JCI5241
Anca D. Dobrian, David C. Lieb, Banumathi K. Cole, David A. Taylor-Fishwick, Swarup K. Chakrabarti, Jerry L. Nadler, Functional and pathological roles of the 12- and 15-lipoxygenases Progress in Lipid Research. ,vol. 50, pp. 115- 131 ,(2011) , 10.1016/J.PLIPRES.2010.10.005
Thomas Horn, Kumar Reddy Kakularam, Monika Anton, Constanze Richter, Pallu Reddanna, Hartmut Kuhn, None, Functional characterization of genetic enzyme variations in human lipoxygenases Redox biology. ,vol. 1, pp. 566- 577 ,(2013) , 10.1016/J.REDOX.2013.11.001
Benedetta Porro, Paola Songia, Isabella Squellerio, Elena Tremoli, Viviana Cavalca, Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product. Journal of Chromatography B. ,vol. 964, pp. 26- 40 ,(2014) , 10.1016/J.JCHROMB.2014.03.015
I Antonipillai, J Nadler, E J Vu, S Bughi, R Natarajan, R Horton, A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease The Journal of Clinical Endocrinology and Metabolism. ,vol. 81, pp. 1940- 1945 ,(1996) , 10.1210/JCEM.81.5.8626861
Carl A Anderson, Fredrik H Pettersson, Geraldine M Clarke, Lon R Cardon, Andrew P Morris, Krina T Zondervan, None, Data quality control in genetic case-control association studies Nature Protocols. ,vol. 5, pp. 1564- 1573 ,(2010) , 10.1038/NPROT.2010.116
L.F. Quintana, B. Guzmán, S. Collado, J. Clària, E. Poch, A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE Kidney International. ,vol. 69, pp. 526- 530 ,(2006) , 10.1038/SJ.KI.5000147